Skip to main content
Premium Trial:

Request an Annual Quote

Celera Diagnostics and UCSF in Breast Cancer Marker Collaboration

NEW YORK, Nov. 7-Researchers at Celera Diagnostics and the University of California, San Francisco will work together to identify genetic markers for breast cancer, the company said today.

 

The collaboration is a large-scale disease association study pairing Celera and UCSF's Comprehensive Cancer Center. Celera Diagnostics and the UC president's office Industry-University Cooperative Research Program will jointly pay for the project.

 

Financial and intellectual property details of the research partnership were not revealed.

 

For further details, see the company statement.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.